Saturday, 28 October 2023

Vitamin D and the second pandemic of the present decade




The first pandemic of the present decade

Early 2020 saw the onset of the Covid-19 pandemic. In the UK, significant numbers occurred in March, and by March 23rd there had been 28 deaths from Covid-19. The government had to do something. As government advisors (mathematician modellers) had predicted huge numbers of deaths, action was essential. It was in the form of “lockdown” on March 23rd, the closure of schools, universities, places of worship, holidays, concerts, most transport, and many places of work.


Figure 1a. The Covid-19 pandemic in the UK in 2020, cases


Damaging as it was to society and the economy, Lockdown had no obvious effect on the number of Covid-19 deaths, which by April 8th had increased to almost 1,000 per day.



Figure 1b. The Covid-19 pandemic in the UK in 2020, deaths


The benefit from UV and vitamin D

After April 2020 there was a progressive decline of cases and also of Covid-19 deaths, to only single numbers each day in the summer (Figure 1b). This should have come as no surprise: it was the result of “nature”. Every year the incidence of respiratory infections is maximal in the winter and progressively reduces to a minimum in the summer. Covid-19 was no exception. This annual phenomenon is the result of an increasing penetration of solar UV to ground level as the Sun rises higher above the horizon. The UV acts on our skin to convert the synthesised 7-dehydrocholesterol (7-DHC) into vitamin D, which is essential for the escalation of defensive immunity. 


Ignoring those at most risk

50% of those who died from Covid-19 in the UK were older than 85 years. The other groups with a high risk of death were the obese, those with Black African and South Asian ethnicity, and Haredi Jews. The great majority of people in all these groups were  known before the appearance of Covid-19 to be seriously deficient of vitamin D. 


Figure 2. Doctors dying from Covid-19  in the UK


Why was this knowledge ignored? This was serious clinical negligence, especially when compounded by the failure to absorb new knowledge published during 2020 and 2021.


Disinformation from the Secretary of State for Health

Matt Hancock, the Secretary of State for Health in 2020, was asked about multiple studies showing a link between serious Covid-19 and vitamin D deficiency. He replied that a British study had found the opposite. Officials have recently admitted that this was not true, and that the health secretary “mis-spoke”. This disinformation meant that vitamin D supplements in appropriate dose were not used to protect against Covid-19 in the UK, and elsewhere. 


Variation of Covid-19 deaths in 2020

It was not surprising that there was an increase in Covid-19 deaths in the autumn of 2020 when the intensity of solar UV declined and the production of vitamin D in the skin diminished. This would be expected, but it is surprising that the peak increased to an even higher level in early 2021. We will follow this shortly.


The importance of vitamin D

Several studies demonstrated that a very low blood level of vitamin D is found in people with critical or fatal Covid-19. It has been pointed out and it is true that a serious infection can reduce the blood level of vitamin D in an individual, but this has not been clearly quantified. It could have been quantified in detail during the 2020 pandemic but if so results are not available. 


However it became clear (especially from Israel) that low blood levels of vitamin D were of great predictive value in respect of a serious critical or fatal Covid-19 outcome, Figure 3. 


Figure 3. Critical care Covid-19  and vitamin D status

We can see in Figure 3 that in this study all (100%) of the Covid-19 cases who were critically ill were vitamin D deficient. 95% were severely deficient with pre-illness blood levels less than 20ng/ml, 50nmol/L. The future opportunity for prevention of illness is glaringly obvious.

In a previous Blog post I reviewed the reports of the benefits of vitamin D in the Covid-19 pandemic.

A typical epidemic/pandemic

We are accustomed to epidemics of disease and deaths, which usually occur during the winter months, especially January to March when the blood levels of vitamin D are at their lowest. The epidemic, if fatal disease, produces a sudden increase in a number of deaths more than expected at that time. It is the vulnerable that usually die, but they can only die once. This means that the increase in the number of deaths for a given population is followed by a compensatory decrease in the number subsequently, in Figure 4. 


Figure 4. The typical pattern of an epidemic

We remember that in early 2020 we saw many deaths from Covid-19, a rapid increase over expected numbers of deaths, followed by reducing numbers in the Spring. But we were only shown Covid-19 deaths at the time, not total number of deaths. It is only from total deaths that we can appreciate a compensatory reduction of deaths. The number of those who died in the pandemic is matched by the subsequent reduction in the number of deaths. This always happens. 


New Zealand

The time-line of the first pandemic is illustrated well by the experience of New Zealand. This information from Our World in Data shows total deaths. We can see in Figure 5 the excess deaths in early 2020 compared with the 2015–2019 average, indicating the initial Covid-19 pandemic. It is followed by a reduction of “excess” deaths, negative, in the following weeks. 


Figure 5. The typical pattern of an epidemic, example from New Zealand



Germany

We have been provided with total deaths occurring in Germany during 2020. The important data concern the proportionate increase or decrease. The baseline of the bar chart shown in Figure 6 is the average during the years 2015 to 2019, expressed as zero for the purpose of comparison with subsequent years.


Figure 6. Germany – excess deaths by age-group in 2020


It is interesting to note that there was only an overall minimal excess deaths during 2020 (grey column in the Figure 6). The excess was only minimal even in people above the age of 70, those who experienced most deaths. The point is that we are looking average deaths per week during all of 2020. The elderly people who died in the initial weeks of the pandemic were no longer alive during subsequent weeks. In other words they were destined by their age and frailty to die during 2020, and the pandemic merely brought forward their deaths by a few weeks or months.


 It is also interesting to look at excess deaths among children of school age. There was a large reduction of deaths, but this could hardly be a direct result of the Covid-19 pandemic. We can only speculate, but it seems to be most likely that the reduction of deaths of children was the result of lock-down, with closure of schools and places of worship, children being confined to the house, and the absence of road traffic should they venture outside. Although Lockdown appears to have reduced the number of deaths of children, there are recent reports that another effect was to reduce the communication skills of children with a negative effect on education.


The second pandemic – excess deaths


Sudden unexpected deaths

During 2022 it became clear that there was an unusually large number of young and middle-aged people dying from “sudden unexpected death”. This phenomenon was often called in the press “heart attacks”, which is a euphemism meaning that individual died suddenly and unexpectedly as presumably the heart suddenly stopped beating. Sometimes the cause of the sudden death has been given as “natural causes”, meaning not trauma or homicide, but from the medical view point this is completely unhelpful. 


We have not had any clear understanding of the results of autopsies in these “sudden and unexpected deaths”, and there are reports of a distinct official policy to discourage or even prevent autopsies being performed. We therefore have little or no knowledge of whether or not there was an underlying or pre-existing disease. 


We must remember that during the 20th century there was a pandemic of coronary heart disease (CHD) with its peak in 1970. This was shown clearly by information from the USA and from the UK. During the pandemic, and especially at its peak,  cardiac arrests were relatively common. This led to the introduction of cardio-pulmonary resuscitation (CPR), defibrillation, and coronary care units (CCUs), unknown before the late 1960s. I qualified in medicine in 1966 and I remember this very well. The underlying heart disease was atherosclerosis in a particularly vicious form. The early stages were identified very clearly in young US soldiers killed in action. It was obvious that the development time from initial disease to clinical and perhaps fatal disease was at least twenty years. The "sudden and unexpected" deaths during the past three years suggests a disease process other than known CHD.


The number of sudden unexpected deaths during 2022 is not known because national data has not been published. When questioned, the UK Chief Medical Officer, Sir Chris Whitty, did not deny the existence of many additional sudden and unexpected deaths, but he suggested that the reason was that people had stopped taking their statin medications (reported on January 18th 2023). The lack of effectiveness of statins is not important at present, but a perusal of the weekly UK reports of medicines dispensed indicates no change in respect of statins during 2022 (Figure 7). More disinformation from government.


Figure 7. Statin prescriptions in England


During 2020 the national newspaper The Guardian drew attention in its news and obituary pages to 49 sudden and unexpected deaths. Without comparison with previous years, this seemed to be a remarkably large number, but The Guardian was unwilling to display the total. During 2023 there have been 18 similar reports or obituaries, but whether the decline is the result of a lower incidence or a change in editorial reporting policy is not clear. The average age at sudden death among these sudden and unexpected deaths was 59 years, range 17 to 78.


There were so many reports of sudden and unexpected deaths in 2021 and 2022 reported in the media. They were inevitably deaths among well-known people, such as Lisa Marie Presley (famous father, 54), Paul Grant (actor, 56), Shane Warne (Australian cricketer, 56), Lance Reddick (actor, 62), Paul Cattermole (musician, 46), Dominic Kwiatkowski (Paediatrician and geneticist, 69), Helen Smart (headteacher and former Olympic swimmer (43), Maddy Cusak (Sheffield United footballer, 27), Ivan Andaur (pilot, 56). Many of the sudden and unexpected deaths were among sports-people, but they were all individual events. They were all human stories, human tragedies but there was little attempt to collate them. 


Figure 8. one of many similar sudden unexplained deaths

More information from Gemany

Further data analysis from Germany looked at diagnostic categories of sudden death and cardiac arrest. The data was that of death from these categories by quarter from 2016, as reported in official international diagnostic (ICD-10) codes. There is a slight gradual increase up to the end of 2020, but then a very sudden increase, a doubling of these deaths in 2021 and the first quarter of 2022. This is alarming, and was obviously not random. 


Figure 9a. Germany – sudden heart deaths by quarter


A similar pattern was seen in the USA, this time looking at the total number of alleged deaths due to vaccinations from 2011 to 2023, Figure 9b. This data is from the official long-standing Vaccine Adverse Events Reporting System (VAERS). Again, something happened in 2011 that had not been experienced previously. The numbers of alleged deaths due to vaccinations was unprecedented.


Figure 9b. USA reports of possible vaccinations deaths


What is it that happened in Germany, the USA, and in other countries in early 2021 that might have caused this abrupt increase of sudden heart deaths, real or possible? Because of official silence on the phenomenon we cannot be certain and therefore speculation is inevitable. The official UK explanations of "not taking statins" or "delayed hospital treatment" are clearly not credible. Take for example, Helen Smart and Maddy Cusak, mentioned above. 


The obvious question is, "What else happened in early 2021 that might have been responsible?" The widespread  Covid-19 vaccination programme at the beginning of 2021 becomes a contender, especially as it soon emerged officially that the new mRNA vaccines could damage the heart causing myocarditis. Exercise in someone experiencing acute myocarditis (perhaps asymptomatic) might be expected to result in a high risk of cardiac arrest.


The role of the mRNA vaccinations has been disputed, but without an alternative credible explanation. Silence from government and other official bodies suggest that there might be something to hide.



Figure 10. Cardiac arrests of footballers ?not a vaccine effect



Excess deaths

Sudden unexplained deaths became obvious during 2021 because they became the experience of people in respect of their friends or family or from reports of sudden unexpected deaths reported in the newspapers. However the total number of deaths in a day/week/month/quarter/year would be outside the experience of an individual and the data can only come from national data collection.


It is important to look at total deaths, and with this the number of deaths in a given time period compared to what is expected from the experience of a previous five-year average. As we have seen above, this gives us a measure of excess deaths.


United Kingdom

Data from the Office of National Statistics (ONS) informed us that in week 21 of 2023 there were 12,528 deaths in the UK. This included 1,076 deaths additional to the number expected compared to the 2015–2019 five year average for this particular week. Covid-19 was written on the death certificate in only 282 of these .


Figure 11. UK ONS – 1074 excess deaths this week


A thousand excess deaths in a week is alarming. Had it been  a result of an earthquake, tsunami, or other natural disaster it would have been visible. But that was not the case. The 1,076 deaths were individuals in different places, just one at a time, peacefully, quietly, unknown to all but their close family and friends. Individuals might have been mentioned in newspaper death announcements, but there was no aggregated death report in the newspapers or medical journals.


The government has remained silent. Government officials will obviously have known about these deaths and there would obviously be detailed discussion behind closed doors. As there would appear to be no public action to be taken, it was in the interests of the government to make no comment.


No doubt through government direction, there has been no report of excess deaths in the general press, but on June 22nd 2023 The Daily Telegraph informed us that “Heart deaths surge by more than 500 a week since pandemic”. These heart deaths are half of total excess deaths, but no detailed analysis was given. The story lasted just a day. 


The BBC has reported the excess deaths of 2022, but again with no sign of government interest.


Figure 12. Excess deaths, BBC report


Excess deaths, Our World in Data
We can look at total deaths in the UK from early 2022, information form Our World in Data. We see the number of deaths expressed as a percentage difference from the 2015 to 1019 average.


Figure 13. UK – excess deaths 2022–2023

The 100% increase in January 2020 was due to the Covid-19 pandemic. The increase in the following winter was when the summer vitamin D production had come to an end. 2021 was the year of vaccinations, intended to bring excess deaths to an end. But in 2022 excess deaths were at about 20%, and in 2023 continuing steadily at about 10%.

The UK government explained the thousands of excess deaths during 2022 as being due to hot weather during the summer. By international standards the UK does not have exceptionally hot summers. Older people were not issued with air-conditioning units during 2023.


Figure 14. UK – excess deaths due to hot weather ?

Stillbirths and neonatal deaths

There has not been a compensatory reduction in deaths, but a continuing excess. The total number of excess deaths can be judged (or counted) as the area under the graph points. Without a compensatory reduction of the number of deaths or an increased birth rate, a reduction of population will be occurring. 


Unfortunately there appears to be a new increase in the number of deaths just before and just after birth, especially in socio-economically disadvantaged families.


Figure 15. UK – excess perinatal deaths, Guardian

Excess deaths of young people

There is a concern that it is not just the elderly who have been dying in excess numbers during 2022 and 2023. Figure 16 shows excess deaths in the 0–24 age group in England. 




Figure 16. England – excess deaths 2022–2023, 0–24 years of age


We can see, as with the experience in Germany, a reduction in expected deaths during the first pandemic, Covid-19. The excess deaths in this age group during 2022 and 2023 is very disturbing, but the detail of causes of these deaths is not yet available.

Edward Dowd is a health insurance expert and data analyst in the USA. He has noted the increasing insurance claims and has also analysed data from the UK Office for National Statistics (ONS). Figure 17 shows his analysis of excess deaths in the UK, young adults aged 15 to 44.



Figure 17. England & Wales – excess deaths ages 15–44



We see a 30% increase of excess deaths in 2021 and 2022. The numbers for 2023 are not yet available.

In the UK there have been in 2023 strikes by doctors who demand a pay increase. The government states that this is the reason for excess deaths, but it would not have an effect beyond the shores of the UK. We will look at what has been happening in other countries.


Ireland                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

In Ireland we see in Figure 18 the current excess deaths at about 20% above expected. This has been persistent during 2021– 2023 and it shows no sign of settling.


Figure 18. Ireland  – excess deaths 2020–2023


New Zealand

We have seen in Figure 5 the excess deaths in New Zealand during 2020, but the time-line of excess deaths in New Zealand  up to the middle of 2023 is seen in Figure 19. It is interesting and alarming, with excess deaths rising to 30% above expected during 2022, but perhaps settling in late 2023.


Figure 19. New Zealand  – excess deaths 2020–2023


Australia

A similar timeline is recorded in Australia, but no data have been recorded since mid-summer. The first pandemic in 2020 had a small effect with compensatory reduction in deaths. But in 2022 we see a second pandemic. Excess deaths have been steady at about 15% during 2023. Once again the area under the graph in Figure 20 indicates total excess deaths, and there has been no compensatory reduction. Excess deaths continue.


Figure 20. Australia  – excess deaths 2020–2023



Germany

We have seen in Figure 6 the interesting information of excess deaths in Germany during the 2020 Covid-19 pandemic. Although excess deaths were minimal in 2020, there was a 2% increase in the 70–79 age group.


Looking at the same data souce, we can see in Figure 21 that 2021 was different: there was an overall 3.5% excess death rate. It was still negative for young people, particularly high (about 7–8%) for the middle aged, but minimal for the elderly. 


Figure 21. Germany  – excess deaths by age group, 2020, 2021, 2022


There were more excess deaths in 2022, 9.5% for the 5–29 age group, and this is particularly alarming. The excess deaths were more than 10% in the 70-79 age group, and overall 6% above the pre-2020 five-year average.


The overall Our World in Data result for Germany is shown in Figure 22.


Figure 22. Germany  – excess deaths 2020–2023


Excess mortality reached a peak of more than 50% above expected levels in late 2022 but is now about 10%.

Europe
The important source of data Eurostat provides further information, but I will just provide the Spring 2023 headline.


Figure 23. Europe – excess mortality

The EU has also released information concerning excess deaths of children, absolute numbers in the EU populations. We can see 1,500 excess deaths in 2022, and 600 excess deaths in the first half of 2023.

Figure 24. Europe  – excess deaths ages 0-14,  2019–2023


Norway

In Norway we can see in Figure 25 the usual variation in numbers of deaths throughout the years 2014 to 2020, with more in the winter, fewer in the summer, but varying around a steady average. The number of excess deaths in the winter is always compensated by fewer than average deaths in the summer.


The excess winter deaths were always less than 1,000, even in 2020, the year of the Covid-19 pandemic. But in 2021 we see a steady increase in the number of deaths, increasing in 2022 to a cumulative excess of 7,000. This trend has been unprecedented, but the 2023 number is not yet available. There appears to be an epidemic starting at the end of 2021. The excess deaths are no longer compensated by below average deaths in the summer, show in Figure 25. The pattern is as in Figures 4 and 5.


Figure 25. Norway – pattern of deaths 2014–2022



The Our World in Data timeline for Norway is below. We can see the Covid-19 epidemic effect in 2020, and a compensatory recovery in early 2021. But in late 2021 and 2022 we can see again what appears to be a second epidemic, of ill-defined fatal illness.


Figure 26. Norway – excess deaths 2020–2023


Canada

Again the same pattern is seen in Figure 27, but with excess deaths increasing to 30% in 2022 and 2023. The sudden drop to 10% excess in April 2023 is encouraging but there is no data beyond that time. The area under the time-line represents the total number of excess deaths. There is no end to this, no compensatory reduction of deaths.



Figure 27. Canada – excess deaths 2020–2023



USA
The pattern of excess deaths shown in Figure 28 is similar to what we have seen in Canada. After peaks of more than 40% excess deaths, the excess still continues steadily at 10% above what is expected from previous experience.

Figure 28. USA – excess deaths 2020–2023


Malaysia
From the far East we can see the example of Malaysia. Similar to Australia and New Zealand, there were few if any excess deaths in 2020, but an epidemic appeared in 2021 and it has not completely settled. It would appear to be something other than Covid-19. It coincided with the introduction of mRNA vaccinations. Deaths continue to be excessive, about 15% above previous average.

Figure 29. Malaysia – excess deaths 2020–2023


End of the pandemic?
As we have seen, we can only conclude that a pandemic is over when we see the compensatory reduction in the number of deaths. We have not yet seen this.


Serious non-fatal illness

Ed Dowd, US data analyst and insurance expert mentioned above, has brought to attention the increase of claims made to life and health insurance companies in the USA concerning the apparent epidemic of sudden deaths in the USA. The reasons for and mechanisms of these deaths have not been defined, and as in the UK and other countries, there has been no official acknowledgement. This book "counts the bodies" and describes the tragedies of the many young people dying far too early in their lives.



Figure 30. "Cause unknown", by Ed Dowd, 2023


Dowd also extracts data from US insurance claims concerning disability resulting in absence from work. The data did not come through government agencies but from the insurance companies themselves. 


We can see in Figures 31 and 32 the pattern of disability resulting in absence from work and claims for insurance. There is an obvious increase in 2022 and 2023, even more obvious in women than in men.



Figure 31. USA: insurance claims for sickness, men


Figure 32. USA: insurance claims for sickness, women



The insurance companies are responsible for paying claims in excess of what they had expected, and this has become greater than the income from those at work. This will produce a financial crisis within the insurance industry.


Dowd also examined ONS data looking to see if there is a similar increase in disabling illness in the UK. There is. 


In the UK there is National Insurance, administered by government agencies. The principle is the same, working people pay and when they are off work on account of illness they receive financial support. The government therefore has accurate records of the numbers of people receiving "sick pay". In current official language, it is called Personal Independence Payment (PIP). 


Figure 33. UK: national insurance calims for sickness, 2016-2023


In previous figures we have seen excess deaths appearing after the Covid-19 pandemic, that is in late 2021, 2022 and 2023 up to the present time. Now we see disabling illness, hopefully short-term and not long-term, but time will tell.

Figure 33 also shows vaccinations, starting at the beginning of 2021. The association is remarkable but whether the illness epidemic is the result of vaccines cannot be concluded. Is there a plausible alternative explanation?


We see indirectly the numbers of excess ill people by noticing the pressures on family doctors and hospitals. The Accident & Emergency departments are overloaded, unable to cope with the numbers. "The busiest ever day in the A&E ward", and this was on June 15th 2023, the middle of the summer, but not excessively hot.


Figure 34. My local newspaper, June 15th 2023.

There are also long delays of several hours before a patient requiring admission can be transferred to an appropriate inpatient ward.


Figure 35. UK numbers of Emergency patients waiting for transfer to a ward

We can see in Figure 35 that this has been a feature since the end of 2021.


The "Debate"

Those who raise alarms about possible vaccine damage are called "antivaxers", and there is much pressure to silence them.


Figure 36. UK: war against anti-vaxers


And also more direct action in social media against "anti-vaxers".

Figure 37. "Not to resist government mandates".

"Not to resist government mandates" is chilling.

There is no debate concerning the pathological mechanism and cause of excess deaths and serious illness, and suspicions of a causative role of vaccines is constantly suppressed. In the UK we can see the attendance in the House of Commons when time was given for a short debate on possible vaccine damage. Hardly an inspiring event, and YouTube showed a clip of members of parliament being actively sent out of the chamber. 

Figure 38. UK: House of Commons debate on possible vaccination damage


After more than 20 attempts, Andrew Brigden, a UK member of parliament, was granted an adjournment debate, late on a Friday afternoon. It took place on Friday October 20th. On this occasion there were about 20 members of parliament present. He gave a convincing presentation on the important topic of excess deaths, and this was followed by a feeble response from a junior government minister.

Figure 39. Andrew Brigden MP

The debate is published in the Parliamentary Hansard, and it is available to the public. There is also a YouTube of the debate, presented by John Campbell.

Figure 40. UK: Hansard report, House of Commons debate on excess deaths



The parliament of Australia made a decision concerning alleged vaccine damaged citizens.

Figure 41. Australia: Senate approach to possible vaccination damage


The "victims" were claimants, but investigation was denied. Hardly transparency.

But the UK government did accept an increase of "sick leave" to a 10 year high, and proposed an answer. 

Figure 42. UK: sick leave due to stress?


There had to some explanation to counter suspicions of vaccination damage. "Stress" is the old stand-by to explaining illness, but it is difficult to define and impossible to measure.

The obviously important policy was to keep the vaccination show on the road. 

Figure 43. UK: Pfizer images to promote vaccinations in 2023

Pfizer led the way with the Marvel characters. There is no time for reflection, despite obvious concerns, and no explanation of or interest in the second pandemic.

Could it be that multiple vaccinations might be the cause of the second pandemic, or might there be another credible possibility? Not hot weather or stress, but perhaps something that has a strong scientific foundation. 

Vitamin D and the Second Pandemic

Remember that an epidemic occurs in one country or one continent. When it occurs in all continents (except Antarctica) it is called a pandemic.

We have seen above that the second pandemic is a true pandemic. The strange thing is that an epidemic or pandemic is usually due to a specific disease or micro-organism, for example Covid-19. This is not the case with the second pandemic of the present decade. The pandemic is an excess of disabling illness and death in all ages, without a defined disease. Without an accurate official count, there appears to be several diseases that are in excess. 

The one that is officially accepted is myocarditis, an inflammation of the heart muscle. It is usually the result of a virus, but the mechanism of the relationship to mRNA vaccination is not clear. The cardiac arrests that have occurred are sometimes reversed by prompt defibrillation, but many are fatal. There is usually no record of pre-existing heart disease.

There is also an increase of neurological disabling illness, such as Guillan-Barré syndrome, a paralytic neuropathy, and facial palsy. There is an increase in deaths from liver cirrhosis, not easy to understand. There is also a curious reduction of deaths from respiratory disease. 

There are convincing reports of an increase in cancer deaths, with activation of cancer in remission, and what have been called "turbo-cancers", very rapidly progressive. This subject has been brought to attention by Angus Dalgliesh, professor of oncology at St George's Hospital Medical School, London. He is a medical practitioner and scientist with a long and distinguished career. He has great experience and a great deal of knowledge to call upon. He has been interviewed at length by Dr John Campbell, and the interview is available on YouTube.

It is as though there is something fundamental that is occurring, that increases susceptibility to a number of diseases, fatal or not. 

There is a parallel and that is AIDS, in which T-cell immunity is suppressed leading to the development of a number of unusual and fatal infections and malignancies. it has been suggested in Australia that this is happening now, what we might call VAIDS, vaccine induced acquired immune deficiency syndrome.

Figure 44. mRNA vaccines damage immunity, from Australia

It is possible that vitamin D deficiency is driving the immune deficiency, as we know that vitamin D is essential for defensive immunity and is a powerful stimulator of the vitally important T-cells.

It was just on September 22nd 2023 the the UK Government  released the information that during 2023 the incidence of tuberculosis, TB, has increased. This is likely to be the result of depressed immunity, especially T-cells, as has been a major feature of AIDS. Depression of immunity at the present time is likely to be a result of repeated mRNA vaccinations.


Figure 45. Increasing incidence of TB in the UK



 I have indicated previously that in the process of defensive immunity a molecule of vitamin D, in its activated form 1,25(OH)D, can be used only once, and then it is inactivated. With repeated infections, or vaccinations (which simulate infections so as to produce an immune response) the body supplies of vitamin D will become depleted. The result will be susceptibility to infections and malignancies.


Figure 46. Hypothetical effect on multiple vaccinations on blood levels of vitamin D

We can see in Figure 46 that the person represented by the blue line starts with a good blood level of vitamin D in its circulating form 25(OH)D, 40ng/ml, 100nmol/L. Despite repeated depletion by immune challenge, this person manages to maintain a blood level above the danger level of 10ng/ml, 50nmol/L.

The person represented by the green line starts of with a low blood level of only 20ng/ml, 50nmol/L, and repeated immune challenges, Covid-19 or vaccinations, soon cause very serious depletion of vitamin D to a level at which fatal illness would be inevitable.

The way to avoid this is to have a constant and adequate supply of vitamin D to maintain a good defensive blood level.

Figure 47. Benefit from vitamin D supplement


In Figure 47 the blue line person is receiving a continuous supplement of vitamin D, and so the depletion following infection or vaccination is rapidly corrected. A good blood level of vitamin D is maintained. The green line person without the vitamin D supplement does not have a good future.

This is a theoretical model but perfectly credible. Appropriate research to confirm or refute the suggestion could easily have been undertaken during the Covid-19 pandemic, but to my knowledge the perhaps unique opportunity has been missed.

There is no official acknowledgment of the value of vitamin D in defensive immunity, despite the knowledge from forty years of research plus a wealth of evidence accumulated during the Covid-19 pandemic.

This can only be regarded as serious neglect, with many lives lost as a consequence.

 























Thursday, 1 June 2023

2023 – a retrospective of vitamin D


My garden today


We are now in the late Spring of 2023. This is my first Blog post of this year, and it had been uncompleted for a few months. I must say that I have been both disappointed and disheartened at the very negative attitude of our medical and political leaders in respect of Vitamin D and natural immunity. But there is a future to think of, and perhaps the importance of Vitamin D will be revealed to the population in the not too distant future.

When the pandemic of Covid-19 arrived in Europe in early 2020, we knew that it would be essential to optimise natural defensive immunity of the population. Although in 1968-69 we had to let the pandemic of "Hong Kong" flu take its course, fifty years later we had accumulated a great deal of research knowledge. In 2020 we knew  how to optimise defensive immunity. We anticipated that as a result of the new knowledge and the correction of widespread Vitamin D deficiency, the deaths from Covid-19 would be very many fewer than during Hong Kong flu pandemic. This has turned out not to be the case: there were thought to have been about 50,000 Hong Kong flu deaths in 1968–69, but as of May 27th 2023 Worldometer reports 225,324 Covid-19 deaths in the UK.

By "we" I mean those people fortunate to have had a background in and knowledge of medical science. I was a young doctor, the  resident medical officer (RMO) of the Manchester Royal Infirmary in 1968-69, and I remember the pandemic very clearly. I subsequently worked as a general internal physician and gastroenterologist in East Lancashire, but I absorbed the new knowledge of the vital importance of Vitamin D in activating defensive immunity. I was also aware of the disturbing extent of Vitamin D deficiency, especially among Black African and South Asian ethnic groups in the UK. 

It turned out to be a naive assumption of mine that in 2020 public health and medical services would want to provide the very best of preventative medicine and treatment of the sick. The knowledge of the importance of Vitamin D was readily available, and it must have been known to public health doctors and the senior medical advisors of government. I was just an ordinary physician in an ordinary hospital in ordinary Lancashire, but as I had been able to absorb the medical-scientific information, surely much more important physicians than I must also have absorbed it. 

Perhaps I seriously underestimated the ignorance of medical scientists who should have known more than I knew. The alternative view is that they deliberately ignored their existing knowledge of the importance of Vitamin D, and deliberately avoided reporting on the new knowledge that appeared during the pandemic.

Pre-pandemic knowledge


Vitamin D had been identified about one hundred years ago, initially through its evolutionary late function of bone maturation. Deficiency of vitamin D was demonstrated to be the cause of rickets in young children, the result of serious atmospheric pollution together with an increasingly indoor life during the industrial revolution. Observation led to the recognition that rickets could be cured by removal of the children from the polluted industrial cities to the alpine villages of Austria, or to the coastal fishing villages of Scotland. The former provided vitamin D production by the action of the sun on the skin, the latter also by the consumption of oily fish, which obtain vitamin D from the oceanic food chain starting in plankton.


It is worth remembering that plankton evolved 1.5 billion years ago, but living at the surface of the oceans they were vulnerable to damage and death from solar UV radiation. They evolved two defensive mechanisms. One was diurnal vertical migration, in which they would sink to a protective depth during the day and rise to the surface during the night, this becoming a genetically controlled process. 


The second protection became the synthesis of the oil molecule 7-dehydrocholesterol, abbreviated as 7-DHC. The important characteristic of 7-DHC is that it absorbs UV energy wavelength 290–315 nm, using the energy to break a specify bond in the molecule rather than it producing heat and radiation damage to the plankton. This sunscreen function is very effective. The by-product of the chemical change is a derivative molecule called cholecalciferol, that we generally know as vitamin D.


Plankton had no use for vitamin D, and it remained a molecule without a function for one billion years. During this important era, evolution was active in producing immunity, essential for further developments of animal life. Ultimately vitamin D gained a function in activating the new immunity cascade, and this was vital to protect against damage from pre-existing bacteria and viruses. The more complex forms of animal life that were to appear during the Cambrian explosion, the "biological big bang", 500 million years ago required this defensive immunity for survival. Fortunately for a fictitious episode of humankind, the invaders in HG Wells’ "War of the Worlds" did not have the benefit of this immune mechanism and they soon succumbed to the micro-organisms with which we share this planet.


To condense a complex process, vitamin D acquired directly from solar UV acting on 7-DHC in our skin, or indirectly by mouth, is not biologically active. It passes in the blood-stream to the liver where a slow process takes place adding a hydroxyl (-OH) group to the molecule. It then returns to the blood as 25(OH)D, also known as calcifediol or calcidiol, and it circulates as a reservoir ready for use when it is needed. At times of microbiological challenge, the cells of immunity, various immunocytes, take up 25(OH)D from the circulation and convert it by the addition of another -OH group into 1,25(OH)D, also known as calcitriol. This is the active form, which unlocks the complex vitamin D receptor (VDR) molecule, and as a result activates  the genes that control the escalation of defensive immunity. An adequate blood level of 25(OH)D is essential for immunity to be maximal and maintained.


The slow process of the conversion of vitamin to into 25(OH)D, calcifediol, in the liver is satisfactory under normal circumstances. It can take up to two weeks for a single dose of vitamin D to reach a peak of 25(OH)D in the blood, but in nature it is a continuous process, at least during the summer months. However, if the part-activated 25(OH)D, calcifediol, is given by mouth, it does not require the liver hydroxylation stage and it reaches  a high (normal) blood level after about two hours. This was first reported by Dr TCB Stamp of University College Hospital London in The Lancet July 20 1974  It was therefore known in advance of the pandemic and we have seen its remarkable importance in clinical studies from Spain, but no clinical use in the UK and other countries.


It had also been established that certain groups within our population, those living closer to the North Pole than to the Equator, are at particular risk of vitamin D deficiency, and thus of sub-optimal immunity. These are in particular citizens whose ethnic origin is in Africa and the Caribbean, or in South Asia, people with a dark skin that is inefficient at producing vitamin D. The pigment melanin in the skin is protective against radiation damage. It absorbs solar UV, which is therefore not available to the substrate 7-DHC. Also vulnerable are the elderly, whose dry skin does not synthesise sufficient 7-DHC to allow production of adequate amounts of vitamin D. Another group vulnerable to serious vitamin D deficiency are people who avoid exposure of the skin to the sun, usually for religious reasons. Finally the obese, in whom the oil vitamin D becomes trapped in the fat cells of the body.


These facts were known, and it was predicted that these groups would be particularly prone to the serious and perhaps fatal effects of the new virus responsible for Covid-19, to which we had no historical or inherited immunity. There was a way of helping people with an ethnic dark skin, the elderly, and the obese, and those who avoided the sun. It would have been possible to contact and provide them with vitamin D supplement, a process that was shown to be feasible in a study by Professor Adrian Martineau. It would however have been much quicker to assume vitamin D deficiency (known to be widespread) and to correct it with a supplement in a dose that would be effective in the deficient but of no danger to those not deficient.


In practice, for reasons that are obscure, this did not happen. It was a callous denial of knowledge by public health bodies and medical organisations. When people developed Covid-19 symptoms and tested to be positive, they were told to go home and then to send for an ambulance only if they had difficulty breathing. How different the outcome might have been if the positive test and been followed by a single dose of vitamin D 100,000 units, a one month supply. Blood test for vitamin D level could also have been performed. The neglect of people with early proven Covid-19 can be viewed as criminal negligence of those responsible for public health.


But despite official disinterest or dismissal, clinical research into vitamin D and Covid-19 was undertaken in many parts of the world.


Clinical Research, 2020 to 2022


Clinical research, like all scientific research, starts with an observation.The next stage is that the observation must be reproduced, and by others. The observation is usually two variable characters that appear to be associated. This association must be consistent, with other of Sir Austin Bradford Hill's criteria of causation. We need to remind ourselves of these, as they are so important,

.

  1. Strength of association
  2. Consistency
  3. Specificity
  4. Temporality
  5. Biological gradient
  6. Plausibility
  7. Coherence
  8. Experiment
  9. Analogy
  10. Reversibility (not always possible)


I drew attention to Hill's Criteria in November 2020, demonstrating that they were fulfilled in respect of a causative role of vitamin D deficiency in Covid-19. Strictly speaking, vitamin D deficiency is not "the cause" of the disease but it is a factor that increases susceptibility to the disease, by disabling immunity. This important because a disease or an injury is generally a product of cause and susceptibility. Serious or fatal forms of the microbial diseases tuberculosis and Covid-19 are due to a combination of the specific micro-organism, and the susceptibility factor of inadequate blood levels of vitamin D. AIDS also makes those affected susceptible to a variety of infections as a result of suppressed immunity.


In a similar way death from a road traffic accident is directly the result of trauma but also perhaps a susceptibility factor of a high level of alcohol in the blood. If government or public health officials want to reduce the number of deaths from road traffic accidents they must minimise susceptiblity factors. There is an enforced maximum allowed blood level of alcohol in car drivers. Public health officials might similarly be expected to demand a minimum blood level of vitamin D, as a way of reducing susceptibility to microbial diseases. It is not happening, in a way that is as negligent as would be ignoring blood levels of alcohol in car drivers.


We can note at present that lessons have not been learned by our medical officials. For example in the British Medical Journal of May 13 2023 contained an article "What is the future for covid drugs and treatments?" There was no mention of optimising natural immunity by correction of vitamin D deficiency.


However not all of clinicial medicine in the UK has been asleep. Supplementation of the population with vitamin D has improved during the pandemic, especially in ethnic minority groups, thanks to the initiatives of individual general medical practitioners, acting independently of government and WHO guidelines.


During the pandemic, which is now officially at an end, I have reviewed 38 papers concerning the benefits of vitamin D in the prevention and treatment of Covid-19. I will present condensed forms of the reviews, but in subsequent Blog posts. 


A new book is about to be available:










Monday, 28 November 2022

Covid-19 & VItamin D: So much evidence of benefit, now from the USA



When the pandemic of Covid-19 emerged two years ago, those medical scientists with a knowledge of the importance of defensive immunity realised that the most immediate and important action must be the correction of Vitamin D deficiency, which is found in the majority of the population. 

Research during the previous forty years had worked out the details of the escalation of defensive immunity in response to infection, information that was not available in the previuos major pandemics of infuenza. The new information involved the vital role of Vitamin D, in its activated form 1,25(OH)D. It was also known that Vitamin D deficiency is very common in the UK and other European countries. It had been established that Vitamin D deficiency is particularly common and severe in certain groups such as the elderly, the obese, people with diabetes or malignancy, and people of South Asian and Black African ethnicity living in Europe. All such groups had a high mortality rate from Covid-19.

Despite advice from independent scientists, those not employed directly by governments, Vitamin D was ignored. The government policies in the US and UK (and elsewhere) were for vaccines to be developed to control Covid-19 infections and for no natural preventative or known pharmaceutical interventions to be considered. 

Deaths from Covid-19

It was not long before Covid-19 caused large numbers of deaths, but those who had died had been offered no immunological protection. Medical scientists who knew of the importance of vitamin D deficiency at this time of pandemic brought this to national attention, but they were ignored. Our political, medical, and public health leaders denied the importance of Vitamin D in the process of immunity. We were perpetually told that there was no evidence that Vitamin D would help in the treatment of Covid-19. Of course there was no specific evidence for the simple reason that the virus was new. We could say the same about vaccines.

But there was good evidence that optimisation of immunity would be an advantage in face of a pandemic, and that Vitamin D is vital for that optimisation. I have pointed out Pascal's Wager, that in the absence of conclusive information (eg the existence of God, or the benfit of Vitamin D in Covid-19) it is important to take the line of least damage and maximum potential benefit. The potential benefit of Vitamin D is far greater than any significant disadvantage, as judged by experience gained during many decades of use. After all, the idea would be to correct deficiency of a natural vitamin/hormone, not to introduce a new and barely-tested medicine.

The denial of VItamin D

Has it been ignorance or ignoring?

Our national officials continued to deny the potential benefits of Vitamin D. They continued to advise witholding VItamin D for immunity optimisation until "proof" of benefit had been demonstrated in a randomised controlled trial (RCT). They seemed to be unaware of the meaning of "proof", and unaware of the serious limitations of an RCT (cost, ethics, logistics). It was obvious that there would be many Covid-19 cases, hospital admissions, and deaths while an RCT would be planned, undertaken, analysed, published, and debated. The realisation of emergency was demonstrated by the introduction of injected mRNA (aka vaccination) given after only rudimentary clinical testing, but natural Vitamin D cheap, safe, and readily available was not allowed.

From May onwards in 2020 nature provided a predictable respite from Covid-19 as the result of the natural summer-time production of Vitamin D, but even this was not officially recognised. Was it ignorance or deliberate ignoring of Vitamin D? Our medical-scientific leaders should not have been ignorant of Vitamin D and its importance in immunity, but supression of that information was essential for the emergency use authorisation (EUA) that would allow the release of new and barely tested "vaccines".

As the pandemic progressed we received a great deal of information concerning the importance of low blood levels of vitamin D in the devlopment of critical and fatal Covid-19, protection by good blood levels (40–50 ng/ml, 100-125nmol/L). The evidence in favour of an important and readily available role for vitamin D in safely minimising the impact of the pandemic has been consistently ignored or suppressed.

Information concerning the importance of vitamin D has continied to accumulate, recently from Belgium and Mexico, and most recently from the USA.

Evidence for the USA

Important evidence became available on November 12th 2022. The study came from the Department of Veterans Affairs (VA) health network in the USA. It was a retrospective cohort study, with the title "Association between vitamin D supplementation and COVID-19 infection and mortality". The authors were from a variety of important medical and university institutions in the USA.

The study identified the records of veterans of the US armed forces, who had blood tests and/or prescriptions for vitamin D between January 1st 2019 and December 31st 2020, which is  before vaccines were introduced. 

34,710 had received a prescription for vitamin D2 (of fungal origin) and 220,265 had received a prescription for vitamin D3 (of animal origin, usually from the oils of sheep's wool). 407,860 controls were identified (no vitamin D supplement taken).

The study objectives were to calculate the time to Covid-19 infection, and the mortality within 30 days of infection.

For the purpose of the study 33,216 subjects treated with vitamin D2 (average age 58) were carefully matched with 33,216 controls (average age 58). 220,265 subjects treated with vitamin D3 (average age 64) were matched with 407,860 controls (average age 63). The details of the matches are shown in the paper.

In the vitamin D3 group, there were 359,091 men and 39,915 women, 71,071 Black and 283, 248 White subjects.

VItamin D results

For the vitamin D3 group, the Vitamin D blood level results before the pandemic are as follows:

Figure1. Blood levels of Vitamin D in the subjects of the USA VA study.
ng/ml and nmol/L

Experience in other observational studies indicates that the risk of critical or fatal Covid-19 is extremely low when the blood level of vitamin D is at or greater than 40 ng/ml, 100 nmol/L. Other studies have show that only about 15 – 25% of people fall into this range. In this present VA study only 25% of the 399,006 subjects had a "good" level of vitamin D, 75% being deficient, and 17% being very deficient with high Covid-19 mortality risk.

Men were found to have on average lower blood levels of vitamin D compared to women.

Black subjects tended to have lower blood levels of Vitamin D and higher rates of Covid-19 infection.

The group taking vitamin D2 was too small for detailed analysis.

The dose of Vitamin D taken had a very wide range, from 20 units per tp 15,000 units.

Outome assessment

There were clear advantages in those taking Vitamin D supplements compared to untreated controls, as shown in Figure 2. The results are displayed as hazard ratios (HR), the control risk being standardised as 1.0 and the Vitamin D treated groups a lower number indicating benefit (lower infection or death rates).

Figure 2. Hazard ratios for Covid-19 infection
based on blood levels of Vitamin D (lower HR greater risk)

For Vitamin D3 treated subjects, the HR for Covid-19 infection is 0.797. For Vitamin D2 treated subjects, the HR for Covid-19 infection is 0.720. The benefit is shown clearly in the bar chart of Figure 3. The outcome for those taking D2 was slightly better than those taking D3, but there was a risk reduction of 25 – 30% for both groups. A clear benefit.


Figure 3. Hazard ratios for Covid-19 infection 
for Vitamin D3 and D2

In Figure 4 we can see that for Vitamin D3 treated subjects, the HR for death within 30 days of Covid-19 infection was 0.667. For Vitamin D2 treated subjects the HR for death within 30 days of Covid-19 infection was 0.765. The outcome for those taking Vitamin D3 (the great majority) was significantly better than for those taking Vitamin D2. 

Figure 4. Hazard ratios for death within 30 days of Covid-19
for Vitamin D3 and D2


For the subjects taking Vitamin D3, the risk reduction for death within 30 days of Covid-19 infection is 33% compared to controls. This a major benefit.

Further information is given in the paper.

The analysis was based on medical records. No toxic effects of Vitamin D were recorded.

The greatest benefit was seen in the subjects with the most severe Vitamin D deficiency, less than 20ng/ml, 50nmol/L. Vitamin D supplement of 50,000 units per day brought about an infection HR of 0.51, which is a 49% reduction of Covid-19 infection risk. This is a great short-term benefit but the dose is very high for long-term use.

The risk reduction for Covid-19 infection in men and women was similar, HR 0.8 in men and HR 0.77 in women, corressponding to 20% and 23% risk reduction respectively.

Figure 5. Hazard ratios for Covid-19 infection
men and women

Risk reduction was greater in Black subjects compared to White.

Figure 6. Hazard ratios for Covid-19 infection
Black and White subjects

The respective HRs indicate a 30% risk reduction for Black subjects receiving a Vitamin D supplement comared to a 20% risk reduction in matched White subjects. This probably represents initially lower blood levels of Vitamin D in the Black subjects.  

Vitamin D: blood levels and supplements.

The USA VA study was retrospective controlled. The variables of initial blood levels of Vitamin D and the dose of Vitamin D supplement were recorded. They were only linked when the analysis was undertaken. The supplements, with a wide range of doses, were not necessarily based on blood levels at the time of prescription. 

It might be expected that those with good blood levels of Vitamin D would not need or be given a supplement, but in practice many were. The results of the study indictate that those with initial very low blood levels of Vitamin D benefited more than those with good blood levels. However those with good blood levels (40ng/ml, 100nmol/L or greater) also benefited. Risk reductions are shown in Figure 7.

Figure 7. Risk reduction from Vitamin D
based on initial blood level of Vitamin D


Thus is very interesting. The subjects with the lowest blood levels of Vitamin D experienced overall a 30% risk reduction for Covid-19 infection. This is good. Those with the next lowest blood levels experienced a 19% risk reduction.

However, the subjects that would not be considered to be Vitamin D deficient experienced a 14% risk reduction when given Vitamin D supplements. This suggests that in advance of a pandemic, giving a Vitamin D supplement to all people would be of considerable advantage, without needing to test for blood levels until later.

Conclusions

This is yet another study that has shown the disadvantage of low blood levels of Vitamin D, and the great medical/biological advantage of correction with a Vitamin D supplement.

How long can our major media, medical scientific, public health, and political leaders continue to ignore and deny the great importance of and benefits from Vitamin D?

From February 2020 onwards many cases of and deaths from Covid-19 could have been prevented if the pre-existing knowledge of the importance and safety of Vitamin D had been been put into action. Of course there was no pre-pandemic experience of Vitamin D supplement in respect of Covid-19, but action could have been taken, the application of Pascal's wager. There was too much demand for "proof" and "more evidence" from people who could not understand the nature of proof. 

The authors state: "When we extrapolate our results for Vitamin D3 supplementation to the entire US population in 2020, there would have been approximately 4 million fewer Covid-19 cases and 116,000 deaths avoided".

If only.....

But for the next pandemic there is official prediction only for more mRNA vaccines, but no mention of Vitamin D, despite all the evidence of effectiveness and safety.




















Tuesday, 27 September 2022

Covid-19 & Vitamin D: RCT benefit in Belgium & Mexico

 


In this Blog post we are going to look at two placebo controlled Randomised Controlled Trials (RCT) that have demonstrated the effectiveness of Vitamin D in reducing the impact of Covid-19. They were performed in Belgium and Mexico. Before this we will recap the UK RCT that I analysed in detail in my previous Blog post.

RCT in the UK

The clinical trial initially undertaken in the UK was intended to evaluate the efficacy of Vitamin D in the prevention of serious Covid-19. It was to be a true Randomised Controlled Trial, but it failed. It was not controlled in that subjects in the control group, being informed that they were not to receive Vitamin D, took Vitamin D on their own initiiative. 

The trial was therefore unable to compare outcome measures of the subjects receiving Vitamin D with true controls. It was also under-powered to answer the question "Should we be promoting Vitamin D to the people of the UK (and elsewhere) to protect them against damaging effects of Covid-19 ?" There were too few serious outcome end-points among the study sample of 6,000 normal healthy volunteers to produce a meaningful result.

The main researcher of the study was Professor Adrian Martineau, more recently commented: 

"The challenges of the Vitamin D RCT – too many are already taking it." 

This means that, as in his study, true controls are unlikely to be available.  


Covid-19 pandemic

The UK study was undertaken during 2020, the first year of the Covid-19 pandemic, when there was clearly a need to give maximum protection to the population. The policy was lockdown and mask-wearing, damaging and probably without benefit. Real protection would come from optimising defensive personal immunity. The national policies were to encourage the devlopment of vaccines for this purpose, but in advance there was the opportunity to use Vitamin D. However natural immunity was never seriously considered officially, despite its success in previous pandemics of respiratory viruses. Vitamin D had the advantages of being available immediately, being very cheap, known to be very safe, and having a strong research foundation of optimising natural defensive immunity.

The ignoring of Vitamin D

Many studies had shown that low blood levels of Vitamin D were associated with and predicted serious or fatal Covid-19, whereas high levels gave a biological advantage. Early clinical trials of Vitamin D (in its rapidly acting part-activated form 25(OH)D Calcifediol) demonstrated clear advantage when given at the time of admission to hospital, but these studies were rubbished in the UK by just three people who were very influential but should have known better. Doctors were advised, directly or indirectly, not to use Vitamin D. We were told that we must wait for the result of the RCT to be conducted by a London team led by Professor Adrian Martineau.

And so we waited patiently. Vaccinations arrived and were given in two phases in 2021 with a booster in early 2022, but nevertheless there were 200,000 Covid-19 deaths in the UK. How many of these deaths might have prevented if Vitamin D been given? Especially if patients admitted to hospital with Covid-19 had been given Vitamin D in its part-activated form Calcifediol, which had been been shown to be very effective in RCTs in Córdoba and Barcelona.

Waiting for the result of the UK RCT turned out to be an exercise in futility: when the result became available in March 2022 it was found to be of no value in assessing the efficacy of Vitamin D (details in previous Blog post). What a wasted opportunity to help the population during the pandemic. 

Meanwhile other studies were in progress.


Liège, Belgium



An RCT study from Belgium was conducted at the University Hospital of Liège. It recruited adult patients admitted to hospital on account of Covid-19 and with blood vitamin D levels of only 20ng/ml (50nmol/L) or less. They were all expected to survive at least 4 days, by which time a significant proportion of the Vitamin D given would be converted into 25(OH)D, calcifediol. Patients taking vitamin D in any form on admission to hospital were excluded.

The patients were therefore all selected as being Vitamin D deficient. They all received high quality clinical care in hospital. They were randomised to receive in addition either Vitamin D 25,000 units as an oil daily for four days to correct deficiency and then 25,000 units weekly for maintenance, or (the controls) to receive an identical liquid oil placebo. 

22 patients were randomised to receive placebo and 21 to receive Vitamin D. The average mean blood level of vitamin D was similar in the two groups. The mean of the placebo group was 16.87 ng/ml, 42.2 mol/L, and of the Vitamin D group 17.87 ng/ml, 44.7 mol/L


Figure 1. Data from the Belgium RCT. (nmol/L = 2.5x ng/ml)

The outcome measures are all in favour of correction of Vitamin D deficiency, even though correction occurred fairly late in the course of Covid-19, but before a clinically critical level was reached. In a small RCT in Brazil, Vitamin D itself given on admission to ICU conferred no benefit, but this was too late and the Vitamin D would take several days to become part-activated to 25(OH)D, Calcifediol. 

We can see in Figure 1 that the length of stay in hospital was reduced by 50% in the Vitamin D group compared to controls (4 versus 8 days).

On day 7 following admission to hospital, 12 out of 22 (55%) control patients were still in hospital, compared to 4 out of 21(19%) of the Vitamin D treated patients.

ICU admission rates were 5 out of 22 (23%) in the control group compared to 2 out of 21 (10%) in the Vitamin D treated group.

Other favourable outcome measurements can be seen in Figure 1, and we can also see that there were 3 Covid-19 deaths in the controls and just one in the Vitamin D treated group.

It is quite clear that this is another RCT that shows that correction of Vitamin D deficiency in defence of patients against Covid-19 is very important. 

Unfortunately during the pandemic doctors have not been allowed to give Vitamin D to hospital patients. How many people have died unnecessarily because of false government dogma?


Mexico City

Mexico City

One of the problems of the UK inconsequential trial was that low risk normal people were recruited. This meant that we could expect only small numbers of important end-points, and there were just three ICU admissions (one in each group) with no deaths. Conclusions could not be drawn, and higher risk subjects would need to be recruited to achieve a meaningful result from a realistic sample size.

The result of an RCT of Vitamin D has been reported from Mexico, and this recruited 321 health-care workers from four hospitals in Mexico City. The study was between July 15th and December 30th 2020, The subjects were considered to be at high risk of serious Covid-19. 94 of the subjects analysed at the end of the study had received Vitamin D 4,000 units daily (a "good" dose), and 98 had received a placebo of identical appearance. Randomisation was successful with no significant differences between the two groups at baseline. More than half the subjects failed to complete the study, mainly the result of too much high pressure work.

Mexico City is only 19 degrees north of the equator (compared to London at 53 degrees) and it is important to note that only 10% of the 321 initially recruited had a blood level of Vitamin D 30ng/ml, 75nmol/L, or more, that is in what other studies have shown to be the safe range. 

Therefore 90% can be judged to be Vitamin D deficient with sub-optimal blood levels.This observation shows that serious Vitamin D deficiency can be common at all latitudes world-wide, the result of indoor working and sun avoidance. 

Further details of baseline Vitamin D status are shown in Figure 2.

Figure 2. Data from Mexico RCT. (nmol/L = 2.5x ng/ml)

The outcome results are also shown in Figure 2. The numbers of subjects are reduced because of the large drop-out rate, explained by the subjects to be the result of very heavy workloads.

During follow-up 24 (24.5%) of the subjects taking placebo tested positive for SARS CoV-2, compared to 6 (6.4%) of the subjects taking Vitamin D. There were no deaths in either group, but one taking placebo required admission to hospital. The blood level of Vitamin D as 25(OH)D, calcifediol, increased significantly in those taking Vitamin D but not in the placebo group.

This was a another positive result of an RCT of Vitamin D in appropriate dose reducing the incidence Covid-19.

https://www.sciencedirect.com/science/article/abs/pii/S0188440922000455?via%3Dihub=&s=09


Conclusion

Vitamin D deficiency is the major risk factor for serious Covid-19, and correction of Vitamin D deficiency has been shown again to give a biological advantage. But once again it has not resulted in a policy of vitamin D encouragement and I have not seen these two studies mentioned in the major media or in the medical press.

Are our medical-scientific leaders detached from current medical research, or are they choosing to deliberately ignore it? There is a single-minded policy of multiple vaccinations, and also what appears to be a deliberate policy of avoiding any debate concerning ineffectiveness and possible resulting damage.












Friday, 26 August 2022

Covid-19 & Vitamin D: UK unhelpful clinical trial

London – Greenwich and Canary Wharf

It has been established very well during the Covid-19 pandemic that a low blood levels of Vitamin D recorded in advance of illness (Santander, Heidelberg, Israel ) is the most significant but potentially reversible risk indicator of critical disease and death. Vitamin D deficiency is also the common factor within the major at-risk groups, the obese, the elderly, and those of South Asian and Black African ethnicity who li
ve in the UK and other northern European countries. 

It has been established that Vitamin D in its "raw" form when given to the critically ill in Intensive Care Units (ICU) is not effective (Brazil), the simple reason being that as we know, it takes up to two weeks for the Vitamin D to be converted in the liver into its hydroxylated pre-active form, 25(OH)D, also known as Calcifediol. When Calcifediol is given by mouth it takes just two hours to achieve good blood levels. It is Calcifediol, 25(OH)D that we measure in the blood as Vitamin D.

Randomised controlled trials (Cordoba and Barcelona) have shown that when Calcifediol is given to patients admitted to hospital on account of severe Covid-19, it is remarkably successful in reducing the risk of escalation to ventilatory care and death. Why it has not been used widely in the UK and elsewhere is a mystery.

Correction of vitamin D deficiency

It would be a sensible public health initiative to correct Vitamin D deficiency within the population, especially in those at particular risk. A "safe" level of Vitamin D in the blood should be achieved, ideally before admission to hospital. Vitamin D is cheap, readily available, and safe when given in physiological doses checked by blood levels. 

It is clear that a low blood level of vitamin D (=Vitamin D deficiency) can be a serious disadvantage, and restoration to an ideal blood level of 40ng/ml (100nmol/L) would be sensible. But how to achieve this is the challenge. 

The physiological way to obtain Vitamin D is by exposure of the skin to the sun, at times when at close to sea level the sun is more than 45 degrees above the horizon, judged by the length of the shadow being less that the height. This could be recommended but an excessive single exposure leading to burn is to be avoided.

It has been demonstrated that not only people with ideal blood levels of Vitamin D have a reduced risk of critical or fatal Covid-19, but also people who are taking vitamin D supplements at the time of hospital admission on account of Covid-19 (Tameside, UK). 

The biology of the pivotal role of Vitamin D, in its fully activated form 1,25(OH)D, in the escalation of natural defensive immunity has been established during the past forty years.

With the onset of a serious pandemic due to a new respiratory virus, it would seem to be sensible to act on a knowledge of medical science supported by early reports of the dangers of low blood levels of Vitamin D. Correcting Vitamin D deficiency would have been of great potential benefit, with no danger. I have drawn attention to the report of just a single case of vitamin D toxicity occurring during the pandemic.

Randomised controlled trial – RCT – from UK

Official advice concerning the use of Vitamin D during the pandemic was very negative, ridiculously so given the circumstances and 200,000 Covid-19 deaths in the UK. The pandemic emergency resulted in vaccines being issued on the basis of Emergency Use Authorisation (EUA), meaning that only short term and rudimentary RCTs in healthy people had been completed. 

When it came to vaccinations in pregnancy there were no RCTs, which can be regarded as negligent. Safety was to be judged on the basis of "post–marketing surveillance". And this is the important thing: the main purpose of RCTs is to establish safety, following the thalidomide tragedy of the 1960s. When taking medicines, effectiveness is less importance than safety. A medicine might not do good, but it must not do harm – primum non nocere.

Whereas the "vaccines" against Covid-19 are a new RNA technology with safety being far from clear, Vitamin D is a natural substance that has been in use for a century. The standard dose range is known, with appropriate blood levels. The exceptionally rare side-effect of Vitamin D intoxication (hypervitaminosis D) is always the result of major dose error and is both easily recognised and completely reversible. The need for RCTs of Vitamin D was much less pressing than for vaccines.

The challenge of prospective randomised trials of vitamin D, or anything else, is that if low-risk individuals are to be studied, very large numbers must be recruited if the endpoint of critical illness or death is to be reached in significant numbers. Administration costs are inevitably very high, and follow-up times will be long. It imight be sensible to concentrate on a smaller number of individuals who are at high risk of serious or fatal Covid-19. Hence the success of the RCTs from Spain, small numbers showing a big effect with statistical significance.

I have also shown in previous Blog posts the wisdom of Sir Austin Bradford Hill, whose criteria of pragmatic "proof" (it is never absolute) identifies an RCT as being only one component. For ethical and operational reasons an RCT might not be possible, or be of only limited value. There is also the wisdom of Blaise Pascal, who realised that decision-making is also pragmatic, a trade-off between likely benefit and possible adverse outcome.


United Kingdom - the COVIDENCE UK study

Early in the pandemic in the UK, a large community-based clinical trial of Vitamin D in the prevention of Covid-19 was proposed by Professor Adrian Martineau. Funding of the study became an immediate problem as a large administrative staff would be essential and there would be no pharmaceutical company support. However the study was undertaken and the result became available in early 2022.

6200 adults were incorporated into the trial, with a number of exclusion criteria including current Vitamin D supplementation. 2958 of these were randomised to receive Vitamin D.

2690 (86.8%) of those to receive VItamin D had blood Vitamin D levels less than 30ng/ml, 75nmol/ml. This shows the extent of clinically significant Vitamin D deficiency. They had suboptimal blood levels as identified in the observational studies described in Heidelberg, Israel, and other places. 

1334 were given a lower dose of vitamin D supplement, 800 units per day, and 1356 were given a higher dose, 3200 units per day.

The controls did not have blood testing and they were informed that they were not to receive a Vitamin D supplement. This is important as, with the Heidelberg and Israel studies, the identification of Vitamin D deficiency before the study would have created the ethical dilemma if they were not to have the deficiency corrected.

There was no placebo given to the control group. This weakened the trial and in the knowledge that they were not to receive Vitamin D that was being tested, the controls would be likely to take a Vitamin D suplement not given to them. In fact 49.9% of them did so on at least one occasion.

The trial commenced in December 2020, with six month follow-up of individuals. The vaccination process was under way at that time and 89.1% of the subjects received one or more doses of a Covid-19 vaccination during the study period. This would obviously complicate the interpretation of the results.

The baseline Vitamin D levels can be seen in Figure 1. Both units in current use are shown, nmol/L and ng/ml. We can see no significance difference between the two treatment groups at the baseline. We see again the high prevalence of low sub-optimal blood levels of Vitamin D.

Figure 1. Baseline blood levels of Vitamin D


In Figure 2 we can see the blood levels of Vitamin D at the end of the study. The ideal blood levels can be judged to be greater than 75nmol/L, 30ng/ml, and preferable to be 100nmol/L, 40ng/ml. We can see that the former level is achieved by taking 800units per day, and the higher level by taking 3,200units per day.

In previous posts I have generally advised a supplement of 3,000units per day (the dose that I take, but as 20,000units once each week) but I have also emphasised the importance of checking blood levels so as to monitor the appropriate dose of the supplement. I have drawn parallels with monitoring the treatment of other hormone deficiencies, namely thyroxine and TSH levels in hypothyroidism, and glucose in diabetes.


Figure 2. End of study blood levels of Vitamin D

It is interesting to note that mean blood level of Vitamin D in the "No offer" group at the end of the study was 66.6nmol/L, 26.6ng/ml. As mentioned above the baseline blood Vitamin D levels in the "No offer" group, the intended controls, were not measured. There is no reason why they should not have been the same as in the treatment groups, which is about 41nmol/L, 16.5ng/ml. The fact that at the end of the study the mean blood level was 66.6nmol/L, 26.6ng/ml, indicates that many of those in the "No offer" were taking Vitamin D supplement of their own initiative, as some admitted. The increase would be 66.5%.

Clinical outcome was of course reported in the results of the study. We can see in Figure 3 that there were no significant differences in the cases of Covid-19 in the three groups, 2.97% in the high dose group, 3.63% in the low dose group, and 2.64% in the "No offer" group. There was similarly no significant difference in hospital admission rate. Ventilation was necessary in only one in each group, and there were no deaths.

Figure 3. Covid-19 infections related to Vitamin D supplement


Figure 4 shows us that there were very few acute respiratory infections, with no significant differences between the groups. The infection rate was highest in the Vitamin D high dose group.

Figure 4. Acute respiratory infection related to Vitamin D supplement


Conclusions

The main conclusion of the study as mentioned in the paper is that a public health policy of Test and Treat Vitamin D Deficiency is a practical proposition. To quote from the paper:

"Ultimately, however, this trial was designed to investigate the effectiveness of a pragmatic 'test–and–treat' approach to boosting population vitamin D status, rather than  biological efficacy of vitamin D to prevent ARIs [acute respiratory infections], and our findings should be interpreted accordingly."

It is not possible to form a conclusion concerning the effectiveness or otherwise of Vitamin D supplementation, but it appears that in prevention among asymptomatic people, a dose of 3,200units is perhaps of no advantage over a lower dose of 800units each day. However the absence of Covid-19 and respiratory deaths in all groups indicates that the study was underpowered (too small) to assess effect on deaths. To do so it would have been necessary recruit at least ten times the number of subjects.

This was a field study and the supplement dose was not adjusted to meet the needs of individual people. It was "one size fits all", but there might be an advantage of personalised approach with intermediate blood testing.

Of greatest importance in assessing Vitamin D efficacy is that the study was compromised by the "control" group being uncontrolled. It would have been scientifically more robust if they had been given a placebo, but that was not the case. This might have been for ethical rather than operational reasons, and similarly no base-line Vitamin D testing for the "control" group. However for a "test-and-treat" evaluation, the management of controls was not important and indeed the presence of controls was not really necessary.

In practice, those randomised to be controls were informed that they were not to receive a Vitamin D supplement, termed "no offer". It would appear that they did not want to miss out on what would be a very safe and potentially great advantage in the face of the pandemic, and many accepted Pascal's Wager, that is they took Vitamin D in unknown amounts, but sufficient to increase the mean blood level of Vitamin D by 66.5%. 

The other confounding factor was the distribution of vaccines at the same time of the study. This was among all groups but it could confuse and diminish any assessment of clinical outcome.

Of 6,000 people taking Vitamin D supplement (including a significant but unknown number of "controls"), only three required ventilatory care for Covid-19 and there were no deaths. This in itself tells us the value of taking a Vitamin D supplement to correct deficiency.

Tracing for and testing of vitamin D deficiency was achieved in this study. 

Assessment of correction of Vitamin D deficiency was inconclusive.

There are of course several other studies, and a study from Mexico will be the subject of the next Blog post.